OCCLXJFHDBDFHV-AOIWGVFYSA-N
C27H33F3N6O5 — CID 121351601
Data last refreshed: (MolForge compound catalog, from PubChem)
About OCCLXJFHDBDFHV-AOIWGVFYSA-N
OCCLXJFHDBDFHV-AOIWGVFYSA-N (PubChem CID 121351601) has the molecular formula C27H33F3N6O5 and a molecular weight of 578.59 g/mol. Its IUPAC name is (9S)-8-N-[4-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-N-[(2R)-1,1,1-trifluoropropan-2-yl]-1,6,8-triazatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-5,8-dicarboxamide.
Molecular Properties
| Compound Name | OCCLXJFHDBDFHV-AOIWGVFYSA-N |
|---|---|
| PubChem CID | 121351601 |
| Molecular Formula | C27H33F3N6O5 |
| Molecular Weight | 578.59 g/mol |
| Exact Mass | 578.25 |
| IUPAC Name | (9S)-8-N-[4-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-N-[(2R)-1,1,1-trifluoropropan-2-yl]-1,6,8-triazatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-5,8-dicarboxamide |
| SMILES | Cc1cc(C(=O)N[C@H](C)C(F)(F)F)nc2c1N1CCC[C@@H](C1)N2C(=O)Nc1cc(OC[C@H]2COC(C)(C)O2)ccn1 |
| InChI | InChI=1S/C27H33F3N6O5/c1-15-10-20(24(37)32-16(2)27(28,29)30)33-23-22(15)35-9-5-6-17(12-35)36(23)25(38)34-21-11-18(7-8-31-21)39-13-19-14-40-26(3,4)41-19/h7-8,10-11,16-17,19H,5-6,9,12-14H2,1-4H3,(H,32,37)(H,31,34,38)/t16-,17+,19+/m1/s1 |
| InChIKey | OCCLXJFHDBDFHV-AOIWGVFYSA-N |
| XLogP | 4.02 |
| TPSA | 118.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 578.59 |
| LogP ≤ 5 | 4.02 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121351601 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.